Epelboym I, et al. – Aim of this study was to evaluate the optimal number and sequence of perioperative chemotherapy cycles in pancreatic cancer (PC). The obtained data indicate that receipt of 6 or more perioperative cycles of chemotherapy either as combined neoadjuvant and adjuvant or adjuvant alone may be correlated with optimal and comparable survival in resected PC.